UF Health researchers awarded $11.8 million grant to fight antibiotic-resistant bacteria
Jürgen Bulitta, Ph.D., is among a team of UF researchers exploring how drug combinations can be tuned to defeat resistant bacteria.
Jürgen Bulitta, Ph.D., is among a team of UF researchers exploring how drug combinations can be tuned to defeat resistant bacteria.
The race to find effective treatments for COVID-19 isn’t just about developing new drugs. University of Florida Health scientists are studying a trio of existing medications known to have broad antiviral activity.
UF College of Pharmacy Associate Professor Jürgen Bulitta, Ph.D., is principle investigator on two grants that will study new drug combinations and new antibiotics to combat a bacterial superbug.